Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.

Bagatell R, Paine-Murrieta GD, Taylor CW, Pulcini EJ, Akinaga S, Benjamin IJ, Whitesell L.

Clin Cancer Res. 2000 Aug;6(8):3312-8.

2.
3.

Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive phosphatidylinositol-3-kinase.

Lemke LE, Paine-Murrieta GD, Taylor CW, Powis G.

Cancer Chemother Pharmacol. 1999;44(6):491-7.

PMID:
10550570
4.

Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.

Engman L, Cotgreave I, Angulo M, Taylor CW, Paine-Murrieta GD, Powis G.

Anticancer Res. 1997 Nov-Dec;17(6D):4599-605.

PMID:
9494575
5.

Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained.

Taylor CW, Wang LM, List AF, Fernandes D, Paine-Murrieta GD, Johnson CS, Capizzi RL.

Eur J Cancer. 1997 Sep;33(10):1693-8.

PMID:
9389935
6.

Human tumor models in the severe combined immune deficient (scid) mouse.

Paine-Murrieta GD, Taylor CW, Curtis RA, Lopez MH, Dorr RT, Johnson CS, Funk CY, Thompson F, Hersh EM.

Cancer Chemother Pharmacol. 1997;40(3):209-14.

PMID:
9219503
7.

Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.

Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, Powis G.

Cancer Res. 1996 Dec 15;56(24):5765-70.

Supplemental Content

Loading ...
Support Center